Western Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$956K Buy
4,762
+23
+0.5% +$4.76K 0.04% 459
2025
Q4
$979K Buy
4,739
+3,568
+305% +$713K 0.05% 357
2025
Q3
$210K Buy
+1,171
New +$199K 0.01% 724
2025
Q2
Sell
-1,179
Closed -$201K 730
2025
Q1
$201K Buy
+1,179
New +$205K 0.01% 653
2024
Q4
Sell
-1,177
Closed -$202K 685
2024
Q3
$202K Sell
1,177
-351
-23% -$58.1K 0.01% 715
2024
Q2
$235K Buy
1,528
+17
+1% +$2.55K 0.02% 578
2024
Q1
$232K Hold
1,511
0.02% 581
2023
Q4
$239K Sell
1,511
-6,755
-82% -$970K 0.02% 612
2023
Q3
$1.21M Buy
8,266
+2,655
+47% +$405K 0.1% 215
2023
Q2
$859K Buy
5,611
+3,272
+140% +$510K 0.07% 273
2023
Q1
$363K Buy
2,339
+658
+39% +$103K 0.03% 451
2022
Q4
$259K Sell
1,681
-1,681
-50% -$248K 0.03% 504
2022
Q3
$445K Hold
3,362
0.03% 524
2022
Q2
$457K Buy
3,362
+747
+29% +$103K 0.03% 499
2022
Q1
$390K Buy
2,615
+900
+52% +$133K 0.02% 600
2021
Q4
$277K Buy
+1,715
New +$277K 0.03% 496
2021
Q2
$265K Sell
1,543
-300
-16% -$49.5K 0.03% 528
2021
Q1
$296K Sell
1,843
-340
-16% -$58.2K 0.04% 404
2020
Q4
$367K Hold
2,183
0.05% 311
2020
Q3
$343K Hold
2,183
0.06% 306
2020
Q2
$368K Buy
2,183
+371
+20% +$58.2K 0.07% 275
2020
Q1
$239K Buy
1,812
+292
+19% +$41.6K 0.05% 309
2019
Q4
$226K Buy
+1,520
New +$209K 0.03% 363

Other funds holding FBT

Western Wealth Management's FBT Position: Q1 2026 in Review

Western Wealth Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.49% in Q1 2026, buying an estimated $4.76K and bringing the position to 4,762 shares worth $956K. The position accounts for 0.04% of the portfolio, ranked #459.

Western Wealth Management first reported a position in FBT in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.21M in Q3 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Western Wealth Management held 4,762 shares of First Trust NYSE Arca Biotechnology Index Fund worth $956K as of Q1 2026.
  • Western Wealth Management bought 23 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $4.76K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Western Wealth Management's portfolio in Q1 2026, its #459 holding.
  • Western Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 23 quarters since.
  • Western Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.21M in Q3 2023.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.